18 Oct, 2024 Irides: Weekly patent litigation update By Robert Burrows Charlie French Naomi Hazenberg Kate O'Sullivan Amy Howlett Christopher Stubbs Rebekka Thomas Eden Winlow +5 more... Show less The Irides Weekly Update is our round-up of patent litigation news highlights from around the world. Taking its name from the plural of...
10 Oct, 2024 Labour’s Employment Rights Bill - published today By Manon Rattle As promised in the King’s Speech back in July (see our previous article), within its first 100 days in office Labour has today published...
07 Oct, 2024 Incoming: MHRA consultation on UK Medical Devices Regulations By Hugo Kent-Egan Alex Denoon On 25 September 2024, the MHRA updated its roll-out of the new medical device regulatory framework for Great Britain. The MHRA aims to...
02 Oct, 2024 TEAM-NB’s interpretation of “Structured Dialogue” between Manufacturer and Notified Body, clarifies little By Alex Denoon Anna Hall TEAM-NB has published a new version (v5.0) of its Code of Conduct for Notified Bodies. While we don’t normally comment on this Code,...
23 Sep, 2024 2024 ABPI Code of Practice launched - orange is the new blue By Jamie Hatzel The ABPI and the Prescription Medicines Code of Practice Authority (PMCPA) have announced the release of the latest edition of the ABPI...
02 Sep, 2024 Abbott Diabetes Care Inc. v Sibio Technology Limited – an update By Gregory Bacon Aida Tohala This article was first published in Kluwer Blog [August, 2024]. Background In June 2024, we reported that in an application for...
19 Aug, 2024 CASGEVY: CRISPR/Cas9 gene therapy now available in England following NICE recommendation By Claire Smith Luca Cericola Vertex Pharmaceuticals announced a reimbursement agreement with NHS England for individuals 12 years or older with transfusion-dependent...
13 Aug, 2024 UK – Samsung Bioepis v. Janssen Biotech / ustekinumab By Sophie Britton This article was first published in EPLAW blog [August, 2024]. Patents Court finds Janssen Biotech’s patent, for the antibody ustekinumab...
25 Jul, 2024 Sanofi/Regeneron succeed against Amgen in first revocation decision issued by a Central Division of the UPC By Rebekka Thomas On 16 July 2024, the Munich Central Division published its decision in an action for revocation by a Sanofi group of companies (Sanofi)...
18 Jul, 2024 GDPR and scientific research in the UK: what are the new government's plans? By Mac Macmillan The King's Speech yesterday (which, for readers not in the UK, sets out the government's legislative plans) promises that the new Digital...
17 Jul, 2024 London's real estate landscape: How life sciences can drive change By Jessica Ebhomenye London's commercial real estate landscape is transforming, driven by the growing life sciences sector, which encompasses biotechnology,...
16 Jul, 2024 “This may hurt a bit…” – Moderna paves the way for COVID-19 vaccine damages claim against Pfizer and BioNTech in the UK By Charlie French This article was first published in Kluwer Patent Blog [July, 2024]. Moderna secured a double victory in the Patents Court last week (2...